Publications
Detailed Information
A Phase II Study of Ifosfamide, Methotrexate, Etoposide, and Prednisolone for Previously Untreated Stage I/II Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Multicenter Trial of the Korean Cancer Study Group
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Tae Min | - |
dc.contributor.author | Kim, Dong-Wan | - |
dc.contributor.author | Kang, Yoon-Koo | - |
dc.contributor.author | Chung, Jooseop | - |
dc.contributor.author | Song, Hong-Suk | - |
dc.contributor.author | Kim, Hyo Jung | - |
dc.contributor.author | Kim, Byung Soo | - |
dc.contributor.author | Lee, Jong-Seok | - |
dc.contributor.author | Kim, Hawk | - |
dc.contributor.author | Yang, Sung Hyun | - |
dc.contributor.author | Yuh, Young Jin | - |
dc.contributor.author | Bae, Sung Hwa | - |
dc.contributor.author | Hyun, Myung Soo | - |
dc.contributor.author | Jeon, Yoon Kyung | - |
dc.contributor.author | Kim, Chul Woo | - |
dc.contributor.author | Heo, Dae Seog | - |
dc.date.accessioned | 2020-04-27T11:25:19Z | - |
dc.date.available | 2020-04-27T11:25:19Z | - |
dc.date.created | 2020-02-19 | - |
dc.date.issued | 2014-11 | - |
dc.identifier.citation | Oncologist, Vol.19 No.11, pp.1129-1130 | - |
dc.identifier.issn | 1083-7159 | - |
dc.identifier.other | 91744 | - |
dc.identifier.uri | https://hdl.handle.net/10371/165416 | - |
dc.description.abstract | Background. Combination chemotherapy consisting of ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) was active as first-line and second-line treatment for extranodal natural killer/T-cell lymphoma (NTCL). Methods. Forty-four patients with chemo-naive stage I/IINTCL were enrolled in a prospective, multicenter, phase II study and received six cycles of IMEP (ifosfamide 1.5 g/m(2) on days 1-3; methotrextate 30 mg/m(2) on days 3 and 10; etoposide 100 mg/m(2) on days 1-3; and prednisolone 60 mg/m(2) per day on days 1-5) followed by involved field radiotherapy (IFRT). Results. Overall response rates were 73% (complete remission [CR] in 11 of 41 evaluable patients [27%]) after IMEP chemotherapy and 78% (CR 18 of 27 evaluable patients [67%]) after IMEP followed by IFRT. Neutropenia and thrombocytopenia were documented in 33 patients (75%) and 7 patients (16%), respectively. Only 8 patients (18%) experienced febrile neutropenia. Three-year progression-free survival (PFS) and overall survival (OS) were 66% and 56%, respectively. High Ki-67 (>= 70%) and Ann Arbor stage II independently reduced PFS (p= 5.004) and OS (p =5.001), respectively. Conclusion. Due to the high rate of progression during IMEP chemotherapy, IFRT needs to be introduced earlier. Moreover, active chemotherapy including an L-asparaginase-based regimen should be use to reduce systemic treatment failure in stage I/II NTCL. | - |
dc.language | 영어 | - |
dc.publisher | AlphaMed Press Inc | - |
dc.title | A Phase II Study of Ifosfamide, Methotrexate, Etoposide, and Prednisolone for Previously Untreated Stage I/II Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Multicenter Trial of the Korean Cancer Study Group | - |
dc.type | Article | - |
dc.contributor.AlternativeAuthor | 허대석 | - |
dc.contributor.AlternativeAuthor | 김철우 | - |
dc.contributor.AlternativeAuthor | 전윤경 | - |
dc.contributor.AlternativeAuthor | 김동완 | - |
dc.contributor.AlternativeAuthor | 이종석 | - |
dc.identifier.doi | 10.1634/theoncologist.2014-0305 | - |
dc.citation.journaltitle | Oncologist | - |
dc.identifier.wosid | 000346601600006 | - |
dc.identifier.scopusid | 2-s2.0-84908547656 | - |
dc.citation.endpage | 1130 | - |
dc.citation.number | 11 | - |
dc.citation.startpage | 1129 | - |
dc.citation.volume | 19 | - |
dc.identifier.sci | 000346601600006 | - |
dc.description.isOpenAccess | Y | - |
dc.contributor.affiliatedAuthor | Kim, Dong-Wan | - |
dc.contributor.affiliatedAuthor | Lee, Jong-Seok | - |
dc.contributor.affiliatedAuthor | Jeon, Yoon Kyung | - |
dc.contributor.affiliatedAuthor | Kim, Chul Woo | - |
dc.contributor.affiliatedAuthor | Heo, Dae Seog | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.